Cell & Gene Therapy INSIGHTS

Innovation Insights March 2021

March 2021

  • Stem cell therapy: current obstacles and innovations

    J Hare
    Joshua Hare
    Chief Sciences Officer, Senior Associate Dean for Experimental and Cellular Therapeutics, Director of the Interdisciplinary Stem Cell Institute (ISCI) and Louis Lemberg Professor of Medicine at the University of Miami Miller School of Medicine
    22 March 2021
  • On my bookshelf...

    Q Rafiq
    Qasim Rafiq
    In CGTI Shelfies, we ask experts within cell and gene therapy to pick the publications that helped shape their field, and their own careers. This week, we take a look into the bookshelf of Qasim Rafiq, Associate Professor in Cell and Gene Therapy Bioprocess Engineering at University College London.
    Associate professor at UCL’s Advanced Centre for Biochemical Engineering, Qasim’s research focus is on addressing translational challenges of robust manufacture of stem cells that are needed to take regenerative medicines into the clinic. This includes the “whole bioprocess” from sourcing of raw materials and cells, through cell expansion in bioreactors and ultimately the downstream processing needed to purify and concentrate cell product for delivery to the patient. He previously lectured in Bioprocess Engineering at Aston University, where he was Principal Investigator on 4 grants with funding from RCUK, EU Horizon 2020, InnovateUK and commercial sources. Qasim completed his PhD at Loughborough.
    16 March 2021
  • On my bookshelf...

    R Deans
    Robert Deans
    CSO at Synthego Corporation
    3 March 2021

Other reports from Cell and Gene Therapy insights